Caspase-8 is an initiator caspase that is essential for apoptotic death triggered by TNFR1. However, there are suggestions that Caspase-8 may also have the opposite function of keeping cells alive but how Caspase-8 mediates a survival signal is not known. In preliminary studies, we found that Caspase-8 does this by cleaving the tumor suppressor CYLD at residue D215 resulting in CYLD's degradation. Because CYLD is required for programmed necrosis or necroptosis, its degradation has the effect of suppressing this form of cell death. CYLD is a deubiquitinase that specifically removes K63-linked, as well as linear M1-linked, polyubiquitin modifications from targets such as Ripk1 and Nemo. In mouse embryonic fibroblasts (MEFs), blocking CYLD cleavage by deleting Casp8 or mutating the cleavage site on CYLD (D215A) causes the cells to undergo necrotic death following TNF stimulation. When CYLD is degraded, there is enhanced ubiquitination of Ripk1 favoring its association with Nemo to form a survival- signaling complex. When CYLD is retained, there is less ubiquitination of Ripk1 favoring its association with the Ripk3-containing necrosome complex. Based on these observations, we propose the hypothesis that caspase-mediated degradation of CYLD is the key event in keeping cells alive after TNF stimulation because this suppresses necrosis. We will test this hypothesis by: (1) characterizing the Caspase-8 complex involved in cleaving CYLD;(2) identifying and characterizing the role of CYLD's targets during necrosis;(3) examining the in vivo consequence of Caspase-8-mediated cleavage of CYLD by generating CYLD-D215A knock-in mice. A clearer understanding of how necrosis is regulated, and whether its dysregulation could lead to inflammation, could indicate whether modulating necrotic death may be of potential therapeutic value in inflammatory disorders such as psoriasis, rheumatoid arthritis and inflammatory bowel diseases where TNF is known to be involved.

Public Health Relevance

TNF is an immune system hormone that is involved in inflammatory disorders such as rheumatoid arthritis, Crohn's Disease and psoriasis. TNF can trigger a type of cell death known as programmed necrosis that is thought to be highly inflammatory. Necrosis is dependent on a molecule called CYLD and our goal is to understand how CYLD is regulated during necrosis. In addition, we will test the idea that an out-of-control CYLD can lead to inflammation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
High Priority, Short Term Project Award (R56)
Project #
1R56AI104521-01A1
Application #
8821821
Study Section
Special Emphasis Panel ()
Program Officer
Leitner, Wolfgang W
Project Start
2014-04-07
Project End
2015-03-31
Budget Start
2014-04-07
Budget End
2015-03-31
Support Year
1
Fiscal Year
2014
Total Cost
$294,999
Indirect Cost
$120,958
Name
Icahn School of Medicine at Mount Sinai
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Ting, Adrian T; Bertrand, Mathieu J M (2016) More to Life than NF-?B in TNFR1 Signaling. Trends Immunol 37:535-545
Legarda, Diana; Justus, Scott J; Ang, Rosalind L et al. (2016) CYLD Proteolysis Protects Macrophages from TNF-Mediated Auto-necroptosis Induced by LPS and Licensed by Type I IFN. Cell Rep 15:2449-61
Justus, Scott J; Ting, Adrian T (2015) Cloaked in ubiquitin, a killer hides in plain sight: the molecular regulation of RIPK1. Immunol Rev 266:145-60